Skip to main content

Table 1 Patient and sample characteristics

From: The microbiome of Crohn’s disease aphthous ulcers

Sample ID Age (years) Gender Disease status Biopsy location Years since diagnosis Montreal location Montreal behaviour Antibiotics Indication for colonoscopy (controls)
1SBAU 40 M CD TI ulcer 8 L1 B1 N  
1SB     CM      
2SBAU 29 F CD TI ulcer 7 L3 B1 N  
2SB     TI      
3LBAU 37 M CD SIG ulcer 18 L2 B1 N  
3LB     AC      
4SBAU 32 M CD TI ulcer 3 L3 B2p N  
4SB     TI      
5LBAU 30 M CD SIG ulcer 6 L3 B1 N  
5LB     SIG      
6RECAU 50 F CD REC ulcer 0 L2 B1 Y  
6REC     REC      
7LBAU 40 M UC SIG ulcer 25 E3 S2 N  
7LB     DC      
8SBAU 34 F CD CM ulcer 15 L3 B2 N  
8SB     ICV      
9SBAU 22 F CD CM ulcer 0 L3 B1 N  
9SB     CM      
10RECAU 22 F CD REC ulcer 0 L3 B1 N  
10REC     REC      
11SBAU 50 M CD TI ulcer 10 L3 B3p N  
11SB    CD TI      
12LBAU 28 M CD SIG ulcer 15 L3 B2 Y  
12LB     DC      
NB1 58 M NC DC  –     Rectal bleeding
NB2 31 F NC AC  –     Constipation
NB5 55   NC TI  –     Altered bowel habit
NB11 33 M NC TI  –     Diarrhoea
NB12 38 M NC TI  –     Rectal bleeding
NB13 35 M NC REC  –     Rectal bleeding
NB15 57 M NC TI  –     Rectal bleeding, abdominal pain
NB17 43 M NC TI  –     Rectal bleeding
NB18 34 M NC TI  –     Rectal bleeding, FHCRC
NB21 53 F NC TI  –     Bloating, abdominal pain
NB23 43 M NC TI  –     FHCRC
NB26 60 F NC SIG  –     Rectal bleeding
NB27 58 M NC TI  –     Polyp surveillance
NB29 37 F NC TI  –     Cancer surveillance
NB37 48 F NC TI  –     Fever of unknown origin
NB39 31 F NC TI  –     Abdominal pain
NB48 20   NC AC  –     Rectal bleeding
  1. CD Crohn’s disease, UC ulcerative colitis, NC normal control, AU aphthous ulcer, SB small bowel, LB large bowel, REC rectum, SIG sigmoid colon, DC descending colon, AC ascending colon, ICV ileocaecal valve, CM caecum, TI terminal ileum, NB normal (mucosa) biopsy, F female, M male, L1 ileal CD, L2 colonic CD, L3 Ileocolonic CD, E3 pancolitis ulcerative colitis (proximal to splenic flexure), B1 non-stricturing non-penetrating, B2, structuring, B3 penetrating, p perianal disease, N ‘no’, Y ‘yes’ FHCRC, family history of colorectal cancer